Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$24,635,807
+$5,638,709 QoQ
Shares Held
97,901
+12.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
#543
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWE & RUSLING INC holds $48,551,537 across 10 Drug Manufacturers - General names. ABBV ranks #1 (50.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
97,901 | $24,635,807 | |
| 2 | AZN |
Astrazeneca PLC
|
42,193 | $8,000,635 | |
| 3 | JNJ |
Johnson & Johnson
|
29,374 | $7,460,114 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,744 | $3,179,604 | |
| 5 | AMGN |
Amgen Inc
|
4,998 | $1,809,875 | |
| 6 | LLY |
ELI LILLY & Co
|
1,076 | $1,290,586 | |
| 7 | PFE |
Pfizer Inc
|
35,247 | $848,747 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,437 | $686,910 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,635,807 | 97,901 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $18,997,098 | 87,347 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $19,682,127 | 86,140 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,784,882 | 89,768 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $16,031,071 | 86,365 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,475,643 | 83,408 | Shares | Sole | 2025-06-17 | |
| 2024-12-31 | $14,864,071 | 83,647 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $14,470,741 | 73,277 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $10,818,109 | 63,072 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,056,383 | 60,716 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,915,888 | 57,533 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,762,193 | 58,783 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $303,816 | 2,255 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $351,410 | 2,205 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $394,005 | 2,438 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $406,253 | 3,027 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $384,737 | 2,512 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $326,489 | 2,014 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $287,995 | 2,127 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $229,547 | 2,128 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $238,008 | 2,113 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $219,578 | 2,029 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $225,765 | 2,107 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $156,348 | 1,785 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $175,251 | 1,785 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $103,618 | 1,360 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||